|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the BAX 10-K filed Feb 19, 2009. Operations
|
Adjustments
|
|||||||||||||
|
Depreciation and amortization
|
631 | 581 | 575 | |||||||||||
|
Deferred income taxes
|
280 | 126 | 8 | |||||||||||
|
Stock compensation
|
146 | 136 | 94 | |||||||||||
|
Realized excess tax benefits from
stock compensation |
(112 | ) | — | (29 | ) | |||||||||
|
Infusion pump charges
|
125 | — | 76 | |||||||||||
|
Impairment and restructuring charges
|
31 | 70 | — | |||||||||||
|
Average wholesale pricing litigation charge
|
— | 56 | — | |||||||||||
|
Acquired in-process and collaboration
research and development |
19 | 61 | — | |||||||||||
|
Other
|
51 | (5 | ) | 34 | ||||||||||
|
Changes in balance sheet items
|
||||||||||||||
|
Accounts and other current receivables
|
(98 | ) | (278 | ) | (16 | ) | ||||||||
|
Inventories
|
(163 | ) | (211 | ) | (35 | ) | ||||||||
|
Accounts payable and accrued liabilities
|
(239 | ) | 1 | 30 | ||||||||||
|
Restructuring payments
|
(50 | ) | (27 | ) | (42 | ) | ||||||||
|
Other
|
(120 | ) | 88 | 91 | ||||||||||
|
|
| |||||||
